GL Sciences Inc. (7705.T)
JPY 2759.0
(1.96%)
JPY 2759.0
(1.96%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.52 Billion | 1.98 Billion | 3.69 Billion | 2.74 Billion | 2.23 Billion | 2.08 Billion |
| Net Income | 3.43 Billion | 6.49 Billion | 4.99 Billion | 3.96 Billion | 2.76 Billion | 3.42 Billion |
| Depreciation & Amortization | 1.72 Billion | 1.58 Billion | 1.18 Billion | 1.15 Billion | 1.1 Billion | 902.98 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -2.33 Billion | -4.07 Billion | -1.33 Billion | -1.51 Billion | -917.76 Million | -967.62 Million |
| Other non-cash items | 6.47 Billion | -2.01 Billion | -1.15 Billion | -859.54 Million | -711.09 Million | -1.26 Billion |
| Investing Cash Flow | -1.68 Billion | -3.59 Billion | -2.94 Billion | -3.49 Billion | -1.59 Billion | -1.21 Billion |
| Investments in PPE | -1.63 Billion | -3.15 Billion | -2.77 Billion | -3.34 Billion | -1.38 Billion | -2 Billion |
| Acquisitions | 11.35 Million | -147.15 Million | -27.69 Million | -19.9 Million | -41.46 Million | 616 Million |
| Investment purchases | -518.97 Million | -889.06 Million | -658.33 Million | -800.87 Million | -526.05 Million | -528.37 Million |
| Sales/Maturities of investments | 460.17 Million | 600.41 Million | 520.58 Million | 691.4 Million | 525.65 Million | 699.23 Million |
| Other Investing Activities | -2.98 Million | -1.59 Million | -5.11 Million | -22.37 Million | -167.05 Million | 4.01 Million |
| Financing Cash Flow | -1.18 Billion | 1.89 Billion | -1.14 Billion | 1.3 Billion | -132.22 Million | -315.16 Million |
| Debt repayment | -350.71 Million | -724.84 Million | -693.12 Million | -616.43 Million | -500.64 Million | -515.5 Million |
| Dividends payments | -665.83 Million | -512.72 Million | -409.47 Million | -307.7 Million | -410.26 Million | -307.55 Million |
| Common Stock Repurchased | -105 Thousand | -2.9 Million | -164 Thousand | -2.67 Million | -728 Thousand | -54 Thousand |
| Common Stock Issuance | - | 3.13 Billion | -40.91 Million | 2.24 Billion | 779.41 Million | 507.95 Million |
| Other Financing Activities | -171.63 Million | -1000.00 | -1000.00 | -14 Million | -1000.00 | -2000.00 |
| Accounts receivables | -995.56 Million | -1.18 Billion | -1.01 Billion | -777 Million | -21 Million | -519 Million |
| Accounts payables | -163.31 Million | 311.73 Million | 527.06 Million | 325.11 Million | -430.54 Million | 357.3 Million |
| Inventory | -1.15 Billion | -3.11 Billion | -749.17 Million | -1.06 Billion | -427.05 Million | -902.9 Million |
| Other working capital | -19.18 Million | -86.38 Million | -98.04 Million | 1.13 Million | -39.16 Million | 96.97 Million |
| Cash at beginning of period | 6.04 Billion | 5.61 Billion | 5.84 Billion | 5.32 Billion | 4.83 Billion | 4.29 Billion |
| Cash at end of period | 6.86 Billion | 6.04 Billion | 5.61 Billion | 5.84 Billion | 5.32 Billion | 4.83 Billion |
| Capital Expenditure | -1.63 Billion | -3.15 Billion | -2.77 Billion | -3.34 Billion | -1.38 Billion | -2 Billion |
| Effect of forex changes on cash | 166.33 Million | 154.64 Million | 165.57 Million | -29.23 Million | -15.78 Million | -12.67 Million |
| Net cash flow / Change in cash | 819.34 Million | 436.12 Million | -235.52 Million | 521.43 Million | 487.68 Million | 542.83 Million |
| Free Cash Flow | 1.89 Billion | -1.17 Billion | 913.13 Million | -600.87 Million | 844.6 Million | 79.78 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.43 Billion | 1.14 Billion | 792 Million | 824 Million | 672 Million | 6.49 Billion |
| Depreciation & Amortization | 1.72 Billion | - | 445.91 Million | 394.62 Million | 418.92 Million | 1.58 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -2.33 Billion | - | - | - | - | -4.07 Billion |
| Other non-cash items | 6.47 Billion | -1.14 Billion | -792 Million | -824 Million | -672 Million | -2.01 Billion |
| Investing Cash Flow | -1.68 Billion | - | - | - | - | -3.59 Billion |
| Investments in PPE | -1.63 Billion | - | - | - | - | -3.15 Billion |
| Acquisitions | 11.35 Million | - | - | - | - | -147.15 Million |
| Investment purchases | -518.97 Million | - | - | - | - | -889.06 Million |
| Sales/Maturities of investments | 460.17 Million | - | - | - | - | 600.41 Million |
| Other Investing Activities | -2.98 Million | - | - | - | - | -1.59 Million |
| Financing Cash Flow | -1.18 Billion | - | - | - | - | 1.89 Billion |
| Debt repayment | -350.71 Million | - | - | - | - | -724.84 Million |
| Dividends payments | -665.83 Million | - | - | - | - | -512.72 Million |
| Common Stock Repurchased | -105 Thousand | - | - | - | - | -2.9 Million |
| Common Stock Issuance | - | - | - | - | - | 3.13 Billion |
| Other Financing Activities | -171.63 Million | - | - | - | - | -1000.00 |
| Accounts receivables | -995.56 Million | - | - | - | - | -1.18 Billion |
| Accounts payables | -163.31 Million | - | - | - | - | 311.73 Million |
| Inventory | -1.15 Billion | - | - | - | - | -3.11 Billion |
| Other working capital | -19.18 Million | - | - | - | - | -86.38 Million |
| Cash at beginning of period | 6.04 Billion | - | 6.99 Billion | 7.95 Billion | 6.04 Billion | 5.61 Billion |
| Cash at end of period | 6.86 Billion | - | 7.03 Billion | 6.99 Billion | 7.95 Billion | 6.04 Billion |
| Capital Expenditure | -1.63 Billion | - | - | - | - | -3.15 Billion |
| Effect of forex changes on cash | 166.33 Million | - | - | - | - | 154.64 Million |
| Net cash flow / Change in cash | 819.34 Million | - | 42.87 Million | -961.42 Million | 1.9 Billion | 436.12 Million |
| Free Cash Flow | 1.89 Billion | - | 891.83 Million | 789.25 Million | 837.85 Million | -1.17 Billion |
2PR4
TOYRF
SRBK
DSFIR
8611
EL